RADIOSENSITIZATION OF C6 GLIOMA BY THYMIDINE AND 41.8-DEGREES-C HYPERTHERMIA

被引:10
作者
COHEN, JD
ROBINS, HI
JAVID, MJ
机构
[1] UNIV WISCONSIN HOSP & CLIN,DEPT NEUROL SURG,MADISON,WI 53792
[2] UNIV WISCONSIN HOSP & CLIN,DEPT NEUROL,MADISON,WI 53792
关键词
brain neoplasm; glioma; hyperthermia; radiosensitization; thymidine;
D O I
10.3171/jns.1990.72.5.0782
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cytotoxic, antiproliferative, and radiosensitizing effects of thymidine (a nucleoside metabolite) were studied using the C6 glioma cell line in vitro. Radiosensitization by a combination of thymidine and 41.8°C hyperthermia was also evaluated. Thymidine concentrations above 100 μg/ml completely inhibited C6 proliferation while concentrations of 100 to 1000 μg/ml (for up to 24 hours) decreased C6 cell survival to as little as 7.4% compared to untreated control cells. Radiosensitivity was enhanced by the administration of thymidine alone (400 μg/ml x 24 hours before irradiation); sensitization by 41.8°C hyperthermia alone (1 hour ending immediately before irradiation) was less pronounced. Thymidine and hyperthermia together produced greater radiosensitization than did heat alone or thymidine alone. These data support the further investigation of thymidine as a neuro-oncology radiosensitizer.
引用
收藏
页码:782 / 785
页数:4
相关论文
共 21 条
[1]   HYPOXIA-MEDIATED NITRO-HETEROCYCLIC DRUGS IN THE RADIOTHERAPY AND CHEMOTHERAPY OF CANCER - AN OVERVIEW [J].
ADAMS, GE ;
STRATFORD, IJ .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (01) :71-76
[2]  
ALBRIGHT N, 1988, USERS GUIDE COMPUTER
[3]  
BLUMENREICH MS, 1984, CANCER RES, V44, P2203
[4]   (ADP-RIBOSE)N PARTICIPATES IN DNA EXCISION REPAIR [J].
DURKACZ, BW ;
OMIDIJI, O ;
GRAY, DA ;
SHALL, S .
NATURE, 1980, 283 (5747) :593-596
[5]   RADIATION RESPONSE OF MAMMALIAN CELLS GROWN IN CULTURE .1. REPAIR OF X-RAY DAMAGE IN SURVIVING CHINESE HAMSTER CELLS [J].
ELKIND, MM ;
SUTTON, H .
RADIATION RESEARCH, 1960, 13 (04) :556-593
[6]  
Fox M, 1985, Basic Life Sci, V31, P435
[7]  
FOX RM, 1979, LANCET, V2, P391
[8]  
KUFE DW, 1981, CANCER, V48, P1513, DOI 10.1002/1097-0142(19811001)48:7<1513::AID-CNCR2820480705>3.0.CO
[9]  
2-Q
[10]  
KUFE DW, 1980, BLOOD, V55, P580